Clinical Trial Update: A Study to Evaluate the Antiviral Activity and Safety of HH-003 Injection in Subjects With HBeAg-Negative Chronic Hepatitis B Treated With Nucleos(t)Ide Reverse Transcriptase Inhibitors [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating HH-003 injection for antiviral activity and safety in HBeAg-negative chronic hepatitis B patients already treated with nucleos(t)ide re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• HH-003

Snippet

Sponsor: Huahui Health | Conditions: Chronic Hepatitis B | Phase 2 | Status: COMPLETED